These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20391014)

  • 1. Development and validation of an immunoluminometric assay (ILMA) for fetuin-A-glycoprotein.
    Bäumer A; Schmidt-Gayk H; Aulmann M; Kim TS
    J Immunoassay Immunochem; 2010; 31(1):10-23. PubMed ID: 20391014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects.
    Wood WG; Lüdemann J; Mitusch R; Heinrich J; Maass R; Frick U
    Clin Lab; 2000; 46(3-4):131-40. PubMed ID: 10791120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced serum fetuin-A in nephrotic children: a consequence of proteinuria?
    Fischer DC; Schaible J; Wigger M; Staude H; Drueckler E; Kundt G; Haffner D
    Am J Nephrol; 2011; 34(4):373-80. PubMed ID: 21893974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum.
    Schulte J; Struck J; Bergmann A; Köhrle J
    Clin Chim Acta; 2010 Sep; 411(17-18):1258-63. PubMed ID: 20493180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoluminometric assay (ILMA) for intact human proinsulin and its conversion intermediates.
    Zilkens TM; Eberle AM; Schmidt-Gayk H
    Clin Chim Acta; 1996 Mar; 247(1-2):23-37. PubMed ID: 8920224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene polymorphisms and serum alpha-2-Heremans-Schmid levels in Italian haemodialysis patients.
    Cozzolino M; Biondi ML; Galassi A; Gallieni M; d'Eril GV; Brancaccio D
    Am J Nephrol; 2007; 27(6):639-42. PubMed ID: 17851232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis.
    Oikawa O; Higuchi T; Yamazaki T; Yamamoto C; Fukuda N; Matsumoto K
    Clin Exp Nephrol; 2007 Dec; 11(4):304-308. PubMed ID: 18085392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.
    Hermans MM; Brandenburg V; Ketteler M; Kooman JP; van der Sande FM; Gladziwa U; Rensma PL; Bartelet K; Konings CJ; Hoeks AP; Floege J; Leunissen KM
    Nephrol Dial Transplant; 2006 May; 21(5):1293-9. PubMed ID: 16396973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
    Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE
    Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoluminometric assay of chromogranin A in serum with commercially available reagents.
    Bender H; Maier A; Wiedenmann B; O'Connor DT; Messner K; Schmidt-Gayk H
    Clin Chem; 1992 Nov; 38(11):2267-72. PubMed ID: 1424122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased fetuin-A levels following treatment with a vitamin D analog.
    Manenti L; Vaglio A; Pasquali S
    Kidney Int; 2010 Dec; 78(11):1187; author reply 1187-9. PubMed ID: 21076451
    [No Abstract]   [Full Text] [Related]  

  • 12. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The physiologic development of fetuin-a serum concentrations in children.
    Häusler M; Schäfer C; Osterwinter C; Jahnen-Dechent W
    Pediatr Res; 2009 Dec; 66(6):660-4. PubMed ID: 19690510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterization of monoclonal and polyclonal antibodies to human alpha 2-HS: development of a two-site ELISA test.
    Akhoundi C; Rochet N; Ferrua B; Rossi B
    J Immunol Methods; 1994 Jun; 172(2):189-96. PubMed ID: 8034971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
    Stubenrauch K; Wessels U; Lenz H
    J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
    Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
    Brandenburg VM; Schlieper G; Heussen N; Holzmann S; Busch B; Evenepoel P; Vanholder R; Meijers B; Meert N; Fassbender WJ; Floege J; Jahnen-Dechent W; Ketteler M
    Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum fetuin-A levels increased following parathyroidectomy in uremic hyperparathyroidism.
    Wang CC; Hsu YJ; Wu CC; Yang SS; Chen GS; Lin SH; Chu P
    Clin Nephrol; 2012 Feb; 77(2):89-96. PubMed ID: 22257538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labelled antibody-based one-step time-resolved fluoroimmunoassay for measurement of free thyroxine in serum.
    Wang Z; Lao HM; Liu T; Li LQ; Li M; Wu YS
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):550-7. PubMed ID: 21885471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of four different luminescence immunoassay systems: CELIA (chemiluminescent immunoassay), SPALT (solid-phase antigen luminescence technique), ILMA (immunoluminometric assay) and ILSA (immunoluminometric labelled second antibody). A critical study of macro solid phases for use in immunoassay systems, Part III.
    Wood WG; Fricke H; Haritz J; Gadow A; Krausz HS; Tode B; Strasburger CJ; Scriba PC
    J Clin Chem Clin Biochem; 1984 May; 22(5):349-56. PubMed ID: 6432936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.